Clinical Trials Browser

Phase 1 × Diabetes Mellitus, Insulin-Dependent, 12 × Nivolumab × Clear all

NCT07476326 2026-04-03

Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma

Phase 1 Not yet recruiting

Diabetes Mellitus, Insulin-Dependent, 12, Melanoma, Neoplasms

NCT03507699 2023-04-18

Combined Immunotherapy and Radiosurgery for Metastatic Colorectal Cancer

Phase 1 Completed

Gastrointestinal

Diabetes Mellitus, Insulin-Dependent, 12, Colonic Neoplasms